CClinicalTrials.gg
Status unknownNCT01883687Updated Jun 21, 2013

Functional Nasal Surgery at the Time of Le Fort I Osteotomy: A Prospective, Single-blind, Randomized Trial

An interventional study of Septoplasty in Surgical Procedure, Unspecified, sponsored by Chang Gung Memorial Hospital. Status unknown at 1 site in Taiwan. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2013-06-21.

Sponsored by Chang Gung Memorial Hospital · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Apr 2013), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
16 Years and older
Sex
All
01

Study summary

Objectives: The aims of this study are (1) to define the effectiveness of functional nasal surgery during Le Fort I osteotomy on nasal obstruction through objective as well as subjective evaluations, (2) to determine guideline for concomitant functional nasal surgery with Le Fort I osteotomy, and (3) to explore possible mechanisms by which functional nasal surgery may reduce nasal obstruction severity.

Design: A prospective, single-blnd, randomized trial. Setting: Chang Gung Craniofacial Center and Department of Otolaryngology (ENT). Patients: A total of 80 Taiwanese patients with unilateral cleft lip and palate and dentofacial deformity (age >16 for females, >18 for males; 40 in experimental and 40 in control groups) Interventions: In the experimental group, all patients will receive Le Fort I osteotomy and septoplasty. In the control group, all patients will receive Le Fort I osteotomy only.

Measurements: All patients will undergo history taking, clinical examination, radioallergosorbent (RAST) examination (before surgery), standard questionnaire and image examination before surgery, one week, 1, 3, 6, 12 and 24 months after surgery. To reduce radiation exposure, cone-beam CT will only be performed before surgery and one week, 12 and 24 months after surgery.

Data Analysis: Independent t and chi-squared tests, correlation coefficients and repeated measures analysis of variance (ANOVA) will be used. Statistical significance is assumed for a p value of less than 0.05.

Key Words: cleft lip palate, nasal septum deviation, Le Fort I osteotomy, septoplasty, effectiveness

02

Conditions studied

  • Surgical Procedure, Unspecified
03

In context

Lead sponsor

Chang Gung Memorial Hospital is the lead sponsor of 1,064 studies on the registry; 235 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Taiwanese adults with dentofacial deformities (DFD)
  2. Have documented nasal obstruction and a hypertrophied inferior turbinate on the contralateral side of the septal deviation
  3. Will undergo bimaxillary surgery including 1-piece Le Fort I osteotomy for DFD at the Craniofacial Center between 2012 and 2013

Exclusion criteria

Exclusion Criteria:

  1. Previous OGS or nasal surgery
  2. Patients with nasal polyposis, rhinosinusitis or neoplasia
  3. Patients with clefts or craniofacial anomaly
  4. Patients with adenoid hypertrophy, nasal valve collapse, uncontrolled asthma or tobacco use
  5. Noncompliance for test
  6. Noncompliance to test schedule
  7. Won't sign informed consent
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Septoplasty

    patients will receive septoplasty together with Le Fort I osteotomy

    Procedure: Septoplasty

  • No intervention
    No septoplasty

    patient will only receive Le Fort I osteotomy

Interventions

  • ProcedureSeptoplasty
06

What researchers measure

Primary outcomes

  1. Changes in symptom severity and health-related quality of life in sinonasal conditions

    Sino-Nasal Outcome Test 22(SNOT-22) questionnaire will be used

    Time frame: before surgery and 24 months after surgery

Secondary outcomes

  1. Changes in nasal patency and congestion

    Acoustic rhinometry will be used

    Time frame: before surgery and 24 months after surgery

  2. Changes of nasal airway volume

    Time frame: before surgery and 24 months after surgery

  3. Changes in transnasal pressure and airway resistance and pressure-flow characteristics

    Rhinomanometry will be used

    Time frame: before surgery and 24 months after surgery

  4. Changes of causative allergens

    RAST examination will be used

    Time frame: before surgery and 24 months after surgery

07

Study locations

1 site
  • Chang Gung Memorial Hospital
    Taoyuan, Taiwan
    • Yu-Fang Liao, PHD · Contact · +886-3-3196200
    • Yu-Fang Liao, PHD · Principal investigator
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 21, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01883687
Lead sponsor
Chang Gung Memorial Hospital
Responsible party
Sponsor
First posted
Jun 21, 2013
Start date
Jun 2013
Primary completion
Apr 2016 (estimated)
Completion
Apr 2017 (estimated)
Last update
Jun 21, 2013

Study contacts

Yu-Fang Liao, PHD
Contact
yufang@cgmh.org.tw
+886-3-3196200 ext. 3500
Yu-Fang Liao, PHD
study director · Chang Gung Memorial Hospital

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion